About the Research:

Our clinical trial is a study conducted on Feline Coronaviruses, which belong to the Coronaviridae family that also includes SARS-CoV-2, the virus responsible for the COVID-19 pandemic.

In cats, the Coronavirus undergoes one or more mutations within the body, taking the form of an infection called FIP (Feline Infectious Peritonitis). FIP is an infection that currently has no established treatment and results in patient mortality at rates exceeding 90% by causing simultaneous multiple organ failure.

Study Details:

Results: 

Treatment Administered in the Study

Patients are administered solely Bioelectrical Modulation with the Dr Biolyse^® device. No supportive drugs or chemicals are used.   

Scope of Treatment Efficacy:

1-    In the Effusive (Wet) FIP form:

·      The inflammation observed in the internal organs healed,      

·      Vascular damage recovered, 

·      The effusion accumulated in the abdomen gradually decreased and disappeared,

·      Hematological and biochemical values returned to normal, 

·      General conditions were observed to improve.

2-    In the Neurological (Dry) FIP Form: ·     

·      The inflammation in the spinal cord and central nervous system healed, 

·      Vision and hearing losses returned to normal, 

·      The uveitis condition in the eye recovered,

·      The tongue and pharynx regained function,

·      Hematological and biochemical values were observed to return to normal.

No serious adverse effects were observed.

This study was prospectively designed on client-owned animals and was conducted with the approval of the local animal experiments ethics committee and the permission of the Republic of Türkiye Ministry of Agriculture and Forestry, Istanbul Provincial Directorate of Agriculture and Forestry, within the framework of VICH GL9 standards and guidelines.